This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Cornell University. Active years: 1997-2004.
Company Filing History:
Years Active: 1997-2004
Title: Paul Szabo: Innovator in Neurological and Viral Research
Introduction
Paul Szabo is a distinguished inventor based in Linden, NJ (US). He has made significant contributions to the fields of neurology and virology, holding a total of 3 patents. His innovative work focuses on methods for diagnosing and treating neurological diseases, as well as inhibiting viral replication.
Latest Patents
One of Szabo's latest patents is titled "Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder." This invention provides a method for assessing the risk of neurodegenerative diseases, particularly Alzheimer's Disease (AD). The method involves comparing the level of anti-β-amyloid-42 (Aβ) antibody in a biological sample to a normal level, where a lower level indicates a higher risk of the disease.
Another notable patent is the "Method of inhibiting viral replication in eukaryotic cells." This invention focuses on inhibiting the post-translational hypusine formation in the intracellular protein eIF-5A. By doing so, it aims to suppress infections by viruses that rely on eIF-5A for their replication. The method involves administering agents that block the formation of hypusine, which can lead to the suppression of viral protein biosynthesis and induce apoptosis in infected cells.
Career Highlights
Paul Szabo is affiliated with Cornell University, where he continues to advance research in his areas of expertise. His work has garnered attention for its potential impact on public health, particularly in the treatment of neurodegenerative diseases and viral infections.
Collaborations
Some of Szabo's notable coworkers include Marc E Weksler and Robert Walter Grady. Their collaborative efforts contribute to the innovative research environment at Cornell University.
Conclusion
Paul Szabo's contributions to the fields of neurology and virology exemplify the importance of innovation in addressing complex health challenges. His patents reflect a commitment to advancing medical science and improving patient outcomes.